Bandingkan Harga & Kinerja Esa Medika Mandiri Tbk. (EMMI) vs Solusi Bangun Indonesia Tbk. (SMCB)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Esa Medika Mandiri Tbk. dan Solusi Bangun Indonesia Tbk.: Esa Medika Mandiri Tbk. diperdagangkan di Rp348 (kapitalisasi pasar 627,43 M, volume 24 jam 1,49 jt), sedangkan Solusi Bangun Indonesia Tbk. diperdagangkan di Rp775 (kapitalisasi pasar 6,99 T). Perbedaan utamanya: Solusi Bangun Indonesia Tbk. jauh lebih besar — sekitar 11,1× kapitalisasi pasar Esa Medika Mandiri Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EMMI | SMCB | |
|---|---|---|
Kapitalisasi Pasar | 627,43 M | 6,99 T |
Volume | 1,49 jt | — |
Lot | 14,86 rb | — |
Perputaran | 522,06 jt | — |
Harga Rata-rata | 351,42 | — |
Nilai Transaksi | 522,06 jt | — |
Harga Ekuilibrium Indikatif | 348 | — |
Volume Ekuilibrium Indikatif | 1,55 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Esa Medika Mandiri Tbk.
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Selengkapnya di halaman EMMI →Tentang Solusi Bangun Indonesia Tbk.
PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.
Selengkapnya di halaman SMCB →
